How many clinical trials are tracked for Proliferative Vitreoretinopathy?

5 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Proliferative Vitreoretinopathy

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Proliferative Vitreoretinopathy

5 trials tracked for Proliferative Vitreoretinopathy: 3 in phase 3 or 4.

5Trials tracked

3Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 4 2 Phase 3 1 Phase 2 1 Other / NA 1

Phase 4 Postoperative Pain Control Following Vitreoretinal Surgery Completed
Phase 4 Isotretinoin for Proliferative Vitreoretinopathy Completed
Phase 3 The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Completed
Phase 2 Bevacizumab Against Recurrent Retinal Detachment Completed
N/A Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.